Losartan 25 milligram capsule
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Shaw Cancer Center
Overview
Losartan 25 milligram capsule is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Losartan 25 milligram capsule clinical trials
Explore related
Medical disclaimer. This page summarizes research about Losartan 25 milligram capsule for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.